SCHEMBL16812756

SCHEMBL16812756

O=C(NC1CCN(Cc2ccc(N3CCOCC3)nc2)CC1)c1cccc(-c2ccc(OC(F)(F)F)cc2)c1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 1/20 0.49
▸ SMO Q99835 3/20 0.47
▸ PGR P06401 1/20 0.46
▸ GPR183 P32249 1/20 0.46
▸ CHRM4 P08173 5/20 0.46
▸ DRD4 P21917 2/20 0.45
▸ HTR2A P28223 2/20 0.45
▸ CCR3 P51677 1/20 0.45
▸ SSTR5 P35346 1/20 0.44
▸ PRKAA2 P54646 3/20 0.44
▸ PRKAB2 O43741 2/20 0.44
▸ PRKAG1 P54619 2/20 0.44
▸ PRKAA1 Q13131 2/20 0.44
▸ PRKAG3 Q9UGI9 2/20 0.44
▸ PRKAG2 Q9UGJ0 2/20 0.44
▸ PRKAB1 Q9Y478 2/20 0.44
▸ CNR2 P34972 1/20 0.43
▸ DRD2 P14416 1/20 0.42
▸ ABL1 P00519 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16812619 0.93 SMO (0.48) HPGDSSMOPGRGPR183CHRM4
SCHEMBL16812752 0.92 SMO (0.54) HPGDSSMOPGRGPR183CHRM4
SCHEMBL16812754 0.92 HPGDS (0.49) HPGDSSMOPGRGPR183CHRM4
SCHEMBL16812615 0.91 PRKAA2 (0.50) SMOPGRGPR183CHRM4DRD4
SCHEMBL18286584 0.91 CHRM4 (0.49) SMOPGRGPR183CHRM4DRD4
SCHEMBL16812755 0.91 HPGDS (0.49) HPGDSSMOPGRGPR183CHRM4
SCHEMBL18286595 0.91 SMO (0.54) SMOCHRM4DRD4HTR2ACCR3
SCHEMBL16812558 0.90 SMO (0.59) SMOPGRGPR183CHRM4DRD4
SCHEMBL16811966 0.89 SMO (0.50) HPGDSSMODRD4CCR3SSTR5
SCHEMBL18286597 0.89 SMO (0.47) SMOPGRGPR183CHRM4DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 HPGDS 229/4885SMO 1/4885PGR 3016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback